| 摘要 |
A screening test for Kaposi's sarcoma-associated herpesvirus in a patient involves obtaining a biological sample from the patient, and assaying for the presence of lytic cycle antigens or antibodies in the sample. In preferred embodiments, fluid samples such as peripheral blood mononuclear cells are screened for antigen of Kaposi's sarcoma-associated herpesvirus, e.g., small viral capsid antigen, or serum is screened for antibodies to that antigen. Preferred methods employ immunoblottin, immunofluorescence, or other immunoassay. |
